Halozyme Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
56.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
4
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.51
|
0.74
|
0.23
|
45.10%
|
|
2022-06-30
|
0.50
|
0.53
|
0.03
|
6.00%
|
|
2022-03-31
|
0.49
|
0.47
|
-0.02
|
-4.08%
|
|
2021-12-31
|
0.41
|
0.42
|
0.01
|
2.44%
|
|
2021-09-30
|
0.42
|
0.55
|
0.13
|
30.95%
|
|
2021-06-30
|
0.41
|
0.66
|
0.25
|
60.98%
|
|
2021-03-31
|
0.32
|
0.37
|
0.05
|
15.63%
|
|
2020-12-31
|
0.53
|
0.50
|
-0.03
|
-5.66%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
1.74
|
|
2021-12-31
|
2.00
|
|
2020-12-31
|
0.90
|
|
2019-12-31
|
-0.50
|
|
2018-12-31
|
-0.55
|
|
2017-12-31
|
0.38
|
|
2016-12-31
|
-0.81
|
|
2015-12-31
|
-0.26
|
|
2014-12-31
|
-0.55
|
|
2013-12-31
|
-0.73
|
|
2012-12-31
|
-0.49
|
|
2011-12-31
|
-0.20
|
|
2010-12-31
|
-0.56
|
|
2009-12-31
|
-0.69
|
|
2008-12-31
|
-0.62
|
|
2007-12-31
|
-0.32
|
|
2006-12-31
|
-0.24
|
|
2005-12-31
|
-0.26
|
|
2004-12-31
|
-0.26
|
|
2003-12-31
|
-0.01
|